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Brief Summary  
This chapter focuses on the management of syncope and collapse in the Emergency Department 
(ED). Syncope is a common reason for ED attendance and it presents a major management challenge 
with regard to the appropriate workup and disposition. Initially a diagnosis of syncope should be 
made considering other syncope mimics that can present with Transient Loss Of Consciousness 
(TLoC) especially seizure, and other causes of collapse such as presyncope, lightheadedness, vertigo, 
disequilibrium and mechanical fall. Once the presenting syndrome of syncope is established, the 
current suggested approach to the syncope patient as advocated by the 2018 European Society of 
Cardiology (ESC) syncope guidelines should be followed. If no obvious underlying cause for the event 
is found, risk stratification should be undertaken to determine which patients likely have benign 
causes of syncope and which are at high risk of short-term and long-term adverse outcome. Red flag 
symptoms should be checked and driving, working, and avocational implications should be fully 
considered according to local protocols. The benefits of a hospital syncope clinical decision unit and a 
rapid access syncope clinic include reduced admissions, reduced length of hospital stay and reduced 
hospital costs. 
(190 words) 
 
  
Syncope is a common reason for Emergency Department (ED) attendance. It can present a major 
challenge in terms of appropriate work-up and disposition. Nearly 50% of patients are admitted to 
hospital, and for many this is unnecessary. In March 2018, the European Society of Cardiology (ESC) 
launched a new version of their guidelines for the diagnosis and management of syncope. [1] These 
syncope guidelines have multidisciplinary representation including for the first time, Emergency 
Medicine. 
 
The guidelines have three main new focuses. Firstly, for the first time there is a section on the 
management of people presenting to the Emergency Department (ED) with syncope. This section 
describes how to diagnose syncope, rule out serious underlying diagnoses (both non-cardiovascular 
and cardiovascular), and if the cause of the patient's syncope remains undiagnosed, to risk stratify 
the patient according to the likely diagnosis. A patient likely to have a reflex or postural syncope will 
be at low risk of a serious outcome (although collapse in the elderly is associated with increased risk 
of adverse outcome). However, a patient likely to have cardiac syncope will be at high risk of a 
serious outcome. Management should then be based on the outcome of this risk assessment.  
 
Previous ESC and NICE guidelines have attempted to aid the clinician in assessing the likely cause and 
risk, but the new guidance is the first to very specifically guide clinicians on which patients should be 
deemed high risk, while also attempting to reduce hospital admission rates with alternative 
investigative strategies (e.g. syncope assessment/ decision units and rapid access syncope clinics). 
The second focus of the new guidelines is to advocate the syncope clinical decision unit, including 
clear recommendations as to how it should be set up. Finally, the guidelines recommend an 
enhanced role for prolonged ECG monitoring in patients with unexplained falls, suspected epilepsy 
and recurrent severe unexplained syncope. 
Has my patient had syncope? 
The term 'syncope' must be carefully applied. It is one of two main causes of transient loss of 
consciousness (TLoC). The other commonest cause for this is epileptic seizure. Differentiating the two 
is not always straightforward. The 2018 ESC guidelines highlight the difficulty of diagnosing TLoC as 
being of syncopal origin (i.e. due to cerebral hypoperfusion) in the ED.1 The SYNcope Expert Research 
Group International (SYNERGI) [2] suggests a pragmatic definition of syncope: 'a transient loss of 
consciousness, associated with inability to maintain postural tone and with immediate spontaneous 
and complete recovery'. [3] A very careful history is needed to differentiate syncope from epilepsy 
and other non-TLoC conditions such as presyncope, lightheadedness, vertigo, disequilibrium, and 
accidental or mechanical collapse (i.e. loss of postural tone).  
 
In the absence of witnesses, information from the patient regarding prodrome, provocation and prior 
history can be useful; information from witnesses, particularly on the time to recovery will be 
extremely helpful (as this is a key factor to differentiate syncope from seizure). Where paramedics 
are involved, examine the ambulance notes for initial observations and review any prehospital ECGs. 
These are a great source of useful information that can be hard to locate later down the line and 
copies should be made when first seen. In most cases clinicians can establish whether the presenting 
problem was syncope, and therefore TLoC patients should not be labelled as 'collapse query cause'. 
This implies a lack of attention to the history of the event and leads to poor patient management, 
treatment and disposition decisions.  
 
How should I approach the patient with syncope? 
Firstly, the diagnosis of syncope should be established with some thought given to the ranking of 
likelihood of various causes. Secondly, any serious underlying diagnoses, both non-cardiac (e.g. 
pulmonary embolism, ruptured abdominal aortic aneurysm) and cardiac (complete heart block on 
presenting ECG) should be sought. If the cause of the patient's syncope remains undiagnosed, then 
risk stratification of the patient should take place according to likely diagnosis. History is key 
(including witness history) and examination should include focused cardiovascular examination. 
 
Risk assessment 
The new ESC guidelines are very clear on risk assessment if the patient's syncope remains 
undiagnosed after initial assessment. Risk assessment is designed to decide whether a patient is likely 
to have reflex or postural syncope (low risk of serious outcome) or cardiac syncope (high risk of 
serious outcome). The guidelines provide a list of high and low-risk features that can be used for ED 
risk stratification. [1] These are summarized below: 
 
Syncopal event 
Low risk: 
 Associated with prodrome typical of reflex syncope (e.g. light-headedness, feeling of warmth, 
sweating, nausea, vomiting) 
 After sudden unexpected unpleasant sight, sound, smell, or pain  
 After prolonged standing or crowded, hot places  
 During a meal or postprandial 
 Triggered by cough, defaecation, or micturition 
 With head rotation or pressure on carotid sinus (e.g. tumour, shaving, tight collars) 
 Standing from supine/sitting position 
High risk (red flag): 
Major 
 New onset of chest discomfort, breathlessness, abdominal pain, or headache 
 Syncope during the exertion (not after it has stopped), or when supine 
 Sudden onset palpitation immediately followed by syncope 
 Minor (high risk only if associated with structural heart disease or abnormal Electrocardiogram; ECG): 
 No warning symptoms or short (<10 s) prodrome 
 Family history of Sudden Cardiac Death (SCD) at young age 
 Syncope in the sitting position 
 
Past medical history  
Low risk:   
 Long history (years) of recurrent syncope with low-risk features with the same characteristics 
of the current episode  
 Absence of structural heart disease 
High risk (red flag): 
Major 
 Severe structural or coronary artery disease (heart failure, low left ventricular ejection 
fraction; LVEF or previous myocardial infarction)  
 Family history of sudden/early/unexplained death (may be the only indication of an inherited 
channelopathy. Whilst some have ECG evidence (e.g. long/short QT syndrome, Wolff-
Parkinson-White Syndrome (WPW), Brugada syndrome) others have none (e.g. 
Catecholaminergic polymorphic ventricular tachycardia; CPVT) 
 
Physical examination 
Low risk: 
 Normal examination 
High risk (red flag): 
 Unexplained systolic blood pressure (BP) in the ED <90 mmHg 
 Suggestion of gastrointestinal bleed on rectal examination 
 Persistent bradycardia (<40 beats per minute; bpm) in awake state and in absence of physical 
training 
 Undiagnosed systolic murmur 
 
ECG 
Low risk: 
 Normal ECG (Physician should seek advice if unsure).  
High risk (red flag): 
Major 
 ECG changes consistent with acute ischaemia 
 Mobitz II second- and third-degree atrio-ventricular (AV) block 
 Slow Atrial Fibrillation (AF) (<40 b.p.m.) 
 Persistent sinus bradycardia (<40 bpm), or repetitive sinoatrial block or sinus pauses >3 
seconds in awake state and in absence of physical training 
 Bundle branch block, intraventricular conduction disturbance, ventricular hypertrophy, or Q 
waves consistent with ischaemic heart disease or cardiomyopathy 
 Sustained and non-sustained Ventricular Tachycardia (VT) 
 Dysfunction of an implantable cardiac device (e.g. inappropriate shock from implantable 
cardioverter defibrillator; ICD, or dysfunctional pacemaker)  
 ST-segment elevation with type 1 morphology in leads V1− V3 (Brugada pattern) 
 QTc >460 ms in repeated 12-lead ECGs indicating long QT syndrome (LQTS) 
Minor  (high risk only if history consistent with arrhythmic syncope) 
 Mobitz I second-degree AV block and 1° degree AV block with markedly prolonged PR interval 
 Asymptomatic inappropriate mild sinus bradycardia (40–50 b.p.m.), or slow AF (40–50 b.p.m. 
 Paroxysmal supraventricular tachycardia (SVT) or atrial fibrillation with rapid ventricular rates 
(especially in the elderly) 
 Pre-excited QRS complex 
 Short QTc interval (≤ 340 ms) 
 Atypical Brugada patterns 
 Negative T waves in right precordial leads, epsilon waves suggestive of arrhythmogenic right 
ventricular cardiomyopathy (ARVC) 
 
Patients with prodrome, recurrent syncope, no structural heart disease, normal ECG, normal physical 
examination and no injury are at low-risk of serious short-term outcome. Patients with no associated 
prodrome or typical precipitating event, syncope when supine or during exertion, family history of 
sudden cardiac death at a young age, a past medical history including structural heart disease or an 
abnormal physical examination or ECG are at greater risk of cardiac syncope. Once ED risk 
stratification has been undertaken, the ESC ED risk stratification flowchart shown in Figure 1 should 
be used to determine subsequent management. [1]  
 
Clinical decision rules 
There are many ED Clinical Decision Rules (CDRs) and risk stratification tools for syncope that use 
medical history, examination and ECG findings to stratify patients by their risk of developing both 
short (i.e. 7-30 day) and long-term (i.e. 1 year) serious outcomes. Examples of these include: 
 ROSE rule [4] 
 San Francisco syncope rule [5,6] 
 OESIL [7] 
 STePS [8] 
 Canadian Syncope Risk Score [9] 
 
It is worth nothing that none of these outperform clinical judgment, [10] tend to have low specificity, 
thus increasing admissions, and have been variably adopted. Some rules and tools have included age 
as a factor. While older patients are undoubtedly at higher risk of an adverse outcome after syncope, 
including age in such tools only reduces their specificity - leading to over admission.   
 
Biomarkers 
Although there is increasing interest in the use of biomarkers such as troponins and brain natriuretic 
peptides for ED syncope risk stratification, these cannot be recommended for routine care at present. 
[11-15] 
 
Red flag features not to be missed 
Patients with the following are at risk of cardiac syncope: 
• No associated prodrome or typical precipitating event 
• Syncope when supine or during exertion 
• Family history of sudden cardiac death at a young age 
• Past medical history including structural heart disease 
• An abnormal physical examination or ECG 
Exercise-associated syncope is defined as syncope occurring during exercise (syncope after exercise is 
commonly reflex). Although most cases are benign (especially those associated with post-exercise 
collapse which are commonly reflex) patients with exercise-associated syncope include groups of 
patients at high risk of sudden death and conditions such as Arrhythmogenic Right Ventricular 
Cardiomyopathy (ARVC), Brugada syndrome and Hypertrophic cardiomyopathy (HCM). Patients with 
trauma (commonly facial due to loss of consciousness, meaning they are unable to put their hand 
out) and those without prodromes and/or without apparent triggers and/or atypical presentation 
(termed non-classical reflex syncope forms) should be considered for further arrhythmia investigation 
even if they are of younger age. This is because arrhythmic syncope is associated with no or less than 
3 seconds of prodrome, while the prodrome lasts up to 3 minutes in reflex syncope. 
 
Does my patient need to be admitted to hospital? 
About half of all patients who present to hospital with syncope will end up being admitted. This is 
likely to be due to a lack of supporting outpatient services (e.g. syncope clinical decision/ ED 
ambulatory unit or rapid access syncope clinic) and the concern of the clinician that the patient might 
be at risk of arrhythmic syncope. In fact, death within 7-30 days of ED attendance with syncope is 
infrequent at approximately 0.8%. [1] Non-fatal serious outcome (e.g. acute myocardial infarction, 
life-threatening arrhythmia, decision to implant a pacemaker or cardiac defibrillator, pulmonary 
embolus, cerebrovascular accident, intracranial haemorrhage, subarachnoid haemorrhage, 
haemorrhage requiring a blood transfusion etc.) within 7-30 days of ED attendance with syncope is 
about 10.5% although in two thirds of these patients the serious outcome was apparent in the ED. 
This suggests that many patients who are currently admitted could safely undergo a short period of 
ED monitoring plus selected echocardiography (if structural/ valvular heart disease or heart failure is 
suspected) in an ED clinical decision/ ambulatory unit, followed by urgent review by a syncope 
specialist in a rapid access syncope clinic. If this setup is not available then patients at risk of cardiac 
syncope should not be discharged from hospital until advanced investigations such as 
echocardiography, ECG monitoring and review from an expert in syncope have been completed. 
 
How should I ECG monitor my patient? 
In addition to the 12-lead ECG, immediate ECG monitoring should be applied when there is a 
suspicion of arrhythmic syncope. The new ESC guidelines [1] support an increased role for prolonged 
ECG monitoring when arrhythmic syncope is suspected. Establishing a cardiac arrhythmia as the 
cause of syncope rests on correlating the arrhythmia with symptoms using monitoring devices, but 
these all have significant drawbacks. Cardiac arrhythmia investigation is usually initiated with the 
Holter monitor, but non-compliance and lack of extended monitoring reduces diagnostic yield to less 
than 20%. Event recorders can monitor over longer periods of time but must be activated and cannot 
detect asymptomatic arrhythmias. External continuous loop recorders are expensive, require 
electrodes and bulky recording devices, and produce a large amount of data, which requires sifting. 
Implantable loop recorders are expensive and necessitate an invasive surgical procedure. 
 
There is also very little evidence to support how long patients suspected of having arrhythmic 
syncope should be monitored for, either in the hospital or outpatient setting. The optimum duration 
of hospital ECG monitoring after the index episode is unclear but is likely to lie between 4 and 24 
hours.  Hospital ECG monitoring should occur in an area in which resuscitation facilities are available. 
Various times for outpatient ECG monitoring have been suggested, from 24 hours to 28 days. The 
PATCH-ED study, which used an ambulatory ECG monitor in ED patients with unexplained syncope, 
identified a symptomatic significant arrhythmia in 1 in 10 patients and a diagnostic finding in 3 in 4. 
[16] In this study, a third of the significant and symptomatic significant arrhythmias were captured 
within the first 24 hours (suggesting a role for prolonged monitoring in the ED or in hospital). The 
majority of the significant and symptomatic significant arrhythmias were captured in the first 7 days, 
but some significant arrhythmias (mainly non-serious and asymptomatic) were picked up between 
days 8 and 14. 
 
Driving 
There have been a number of high-profile cases of syncope while driving leading to serious 
consequences. [17] It is vital that all people presenting with syncope are assessed for and counselled 
with respect to their fitness to drive, and that this is detailed in their medical notes. Current local 
fitness to drive guidelines might not always be easily recalled but should be available to access in the 
ED. Note that whilst guidelines will be very different in every country (and often within different 
regions of the same country as in the USA), in the UK, any patient with suspected cardiovascular 
syncope, cough syncope or unexplained syncope and any Class 2 (Heavy Goods Vehicle) driver with 
vasovagal syncope must not drive from the time of their index presentation [Figure 2]. Patients who 
have been told to refraim from driving should be referred to a syncope specialist to confirm the 
diagnosis and receive ongoing driving advice. 
 
Should my hospital have a syncope clinical decision unit? 
The current use of observation wards and syncope clinical decision units is not widespread; for 
example only 27% of UK EDs have an observation ward that admits syncope patients. [18] The new 
ESC syncope guidelines promote the use of syncope clinical decision units within the ED. They allow a 
period of ECG monitoring for patients thought to be at risk of arrhythmic syncope and selected 
echocardiography if structural or valvular heart disease, or heart failure, is suspected. Shen et al [19] 
showed that a designated syncope unit in the ED, where patients could stay for up to 6 hours, 
significantly improved diagnostic yield in the ED and reduced hospital admission and total length of 
hospital stay, without affecting recurrent syncope and all-cause mortality. Patients underwent 
continuous cardiac monitoring, hourly vital sign check, echocardiography in patients with abnormal 
cardiovascular examination findings or an abnormal ECG, tilt-table testing and electrophysiological 
consultation if indicated. Similarly, Sun et al  [20] showed that an ED observation syncope protocol 
reduced admissions, length of hospital stay and index hospital costs, with no difference in safety 
events, quality of life, or patient satisfaction. Patients in this study received continuous cardiac 
monitoring, echocardiogram (for patients with a cardiac murmur on chest auscultation) and 
additional testing at the ED clinician's discretion. Guidelines on setting up a syncope clinical decision 
unit are also available through the ESC. [21] 
 
Should my hospital have a rapid access syncope clinic? 
The current use of specialist syncope outpatient clinic is also not widespread; for example only 18% 
of UK EDs have access to a specialist syncope outpatient clinic. [18] The new ESC syncope guidelines 
promote the use of rapid access syncope clinics as a safe way to reduce admissions and ensure 
patients receive timely, focused expert opinion and investigation. Setting up a syncope rapid access 
syncope clinic in your hospital requires a multidisciplinary team approach, including emergency 
medicine, acute medicine, care of the elderly, neurology, cardiology, electrophysiology, nursing, 
cardiac imaging and neurophysiology, keen enthusiasts (a syncope site champion) and a lot of energy. 
All these disciplines do not need to be co-located, and in the simplest form can be brought together 
in a virtual clinic joined through a well-constructed pathway that signposts referring ED, acute 
medical and GP clinicians to the right place for their patient - be that the TIA/ stroke clinic, neurology 
clinic, first seizure clinic, general cardiology clinic, electrophysiology clinic, admission or the rapid 
access syncope clinic. There are no recommendations as to the timing of when patients requiring 
syncope clinic follow-up should be seen but sooner the better. If the patient was not seen by a 
syncope specialist in the ED observation facility or whilst an inpatient this should be on an urgent 
basis within 2 weeks. 
 
Conclusion 
Patients with syncope commonly present to the ED and present a major workup and disposition 
challenge. The 2018 European Society of Cardiology (ESC) syncope guidelines suggest an approach 
initially making a diagnosis of syncope and seeking an underlying cause. If no obvious underlying 
cause is found, risk stratification should take place occur to determine risk of adverse outcome. Red 
flag symptoms should be considered and implications for driving should be fully considered. 
Establishing a hospital syncope clinical decision unit and rapid access syncope clinic is likely to reduce 
admissions, reduce length of hospital stay and reduce hospital costs. 
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Figure legends   
 
Figure 1:  Emergency department risk stratification flowchart to determine syncope patient 
management of syncope. SU, syncope unit. Reproduced from Brignole M, Moya A, de 
Lange FJ, et al, 2018 ESC Guidelines for the diagnosis and management of syncope, 
European Heart Journal 2018; 39 (21): 1883–1948, doi:10.1093/eurheartj/ehy037. [1] 
Reprinted by permission of Oxford University Press on behalf of the European Society 
of Cardiology. v1.4 
 
Figure 2:  UK Fitness to Drive in TLoC  
(adapted from A. Hudson, S. Saunder, R. Grant, St. George's University Hospital, 
London and based on March 2018 UK Driving and Vehicle Licensing Authority; DVLA 
advice. 1 = UK Class 1 driver's licence, 2 = UK Class 2 Heavy Goods Vehicle driver's 
licence) 
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